Oncolytics Biotech (ONCY) Reports Q2 Loss of $0.13/sh

Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.13), versus ($0.17) reported last year.

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c